Frequency of TERT promoter mutations in human cancers

Vinagre, João, Almeida, Ana, Pópulo, Helena, Batista, Rui, Lyra, Joana, Pinto, Vasco, Coelho, Ricardo, Celestino, Ricardo +16 more·2013·Nature Communications

DOI 10.1038/ncomms3185

Cited by (886)

Items 401–500 of 886

Occurrence, functionality and abundance of the TERT promoter mutations
Sivaramakrishna P. Rachakonda, Jörg D. Hoheisel, Rajiv Kumar · 2021 · International Journal of Cancer
Regulatory grammar in human promoters uncovered by MPRA-based deep learning
Lucía Barbadilla-Martínez, Noud H.M. Klaassen, Vinícius H. Franceschini-Santos, Jérémie Breda, Hatice Yücel, Miguel Hernández-Quiles, Tijs van Lieshout, Carlos G. Urzúa-Traslaviña, Minh Chau Luong Boi, Maryam Akbarzadeh et al. · 2026 · Nature
Variant Profiling of Candidate Genes in Pancreatic Ductal Adenocarcinoma
Jiaqi Huang, Matthias J. Löhr, Magnus H. L. NILSSON, Ralf Segersvärd, Hans Matsson, Caroline Sophie Verbeke, Rainer Lothar Heuchel, Juha Kere, Anthony John Iafrate, Zongli Zheng et al. · 2015 · Clinical Chemistry
Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients.
Mi Ryung Roh, Kyu-Hyun Park, Kee Yang Chung, Sang Joon Shin, Sun Young Rha, Hensin Tsao · 2017 · PubMed Central
Molecular profiling of clear cell adenocarcinoma of the urinary tract
Chieh‐Yu Lin, Atif Saleem, Henning Stehr, James L. Zehnder, Benjamin A. Pinsky, Christian A. Kunder · 2019 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches
Ali Salimi Jeda, Fariba Badrzadeh, Maryam Esghaei, Asghar Abdoli · 2021 · Cancer Treatment and Research Communications
Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway
Jian Carrot‐Zhang, Xiaotong Yao, Siddhartha H. K. Devarakonda, Aditya S. Deshpande, Jeffrey S. Damrauer, Tiago C. Silva, Christopher K. Wong, Hyo Young Choi, Ina Felau, A. Gordon Robertson et al. · 2021 · Cell Reports
TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea
Min Jhi Kim, Jin Kyong Kim, Gi Jeong Kim, Sang‐Wook Kang, Jandee Lee, Jong Ju Jeong, Woong Youn Chung, Daham Kim, Kee‐Hyun Nam · 2022 · Cancers
Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients
Silvia Giunco, Marta Padovan, C. Angelini, Francesco Cavallin, Giulia Cerretti, Marzia Morello, Mario Caccese, Beatrice Rizzo, Domenico D’Avella, Alessandro Della Puppa et al. · 2023 · ESMO Open
TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type
Talal El Zarif, Marc Machaalani, Rashad Nawfal, Amin H. Nassar, Wanling Xie, Toni K. Choueiri, Mark M. Pomerantz · 2023 · The Oncologist
Altered TERT promoter and other genomic regulatory elements: occurrence and impact
Barbara Heidenreich, Rajiv Kumar · 2017 · International Journal of Cancer
Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus
Atsushi Kihara, Yusuke Amano, Taichiro Yoshimoto, Daisuke Matsubara, Noriyoshi Fukushima, Hiroyuki Fujiwara, Toshiro Niki · 2019 · The American Journal of Surgical Pathology
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells
Karolin Walter, Eva Rodríguez-Aznar, Mónica S. Ventura Ferreira, Pierre‐Olivier Frappart, Tabea Dittrich, Kanishka Tiwary, Sabine Meessen, Laura Lerma, Nora Daiß, Lucas-Alexander Schulte et al. · 2021 · Cancers
TERT Promoter Mutation as an Independent Prognostic Marker for Poor Prognosis MAPK Inhibitors-Treated Melanoma
Pauline Blateau, Étienne Coyaud, Estelle M. N. Laurent, Benoît Béganton, Vincent Ducros, Géraldine Chauchard, Julie A. Vendrell, Jérôme Solassol · 2020 · Cancers
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
María Monteagudo, Paula Martínez, Luis Javier Leandro-Garcia, Ángel M. Martínez‐Montes, Bruna Calsina, Marta Pulgarín-Alfaro, Alberto Díaz‐Talavera, Sara Mellid, Rocío Letón, Eduardo Gil et al. · 2021 · Cancers
Prognostic implication of TERT promoter mutation and circulating tumor cells in muscle-invasive bladder cancer
Raquel Carrasco, Mercedes Ingelmo‐Torres, Ascensión Gómez, Fiorella L. Roldán, Natalia Segura, María José Ribal, Antonio Alcaraz, Laura Izquierdo, Lourdes Mengual · 2022 · World Journal of Urology
TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance
Paolo Boscolo‐Rizzo, Giancarlo Tirelli, Jerry Polesel, Egidio Sia, Veronica Phillips, Daniele Borsetto, Anita De Rossi, Silvia Giunco · 2023 · Oral Oncology
Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
Nessn Azawi, Juan Luis Vásquez, Thomas Dreyer, Cathrine Silberg Guldhammer, Rami Muthanna Saber Al-Juboori, Anna Munk Nielsen, Jørgen Bjerggaard Jensen · 2023 · Cancers
Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects
Iñigo Landa, Caitlin E.M. Thornton, Bin Xu, Jacob Haase, Gnana Prakasam Krishnamoorthy, Jingzhu Hao, Jeffrey A. Knauf, Zachary T. Herbert, Paula Martínez, Marı́a A. Blasco et al. · 2023 · Molecular Cancer Research
Telomerase reverse transcriptase promoter mutations in cancers derived from multiple organ sites among middle eastern population
Abdul K. Siraj, Rong Bu, Kaleem Iqbal, Sandeep Kumar Parvathareddy, Nabil Siraj, Sarah Siraj, Mark Diaz, Dionne Rala, Allianah D. Benito, Maria Angelita Sabido et al. · 2019 · Genomics
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma
Charlée Nardin, Caroline Laheurte, Eve Puzenat, Laura Boullerot, Mélanie Ramseyer, Amélie Marguier, Marion Jacquin, Yann Godet, François Aubin, Olivier Adotévi · 2021 · Journal of Investigative Dermatology
Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models
Dmitry Svetlichnyy, Hana Imrichová, Mark W. E. J. Fiers, Zeynep Kalender Atak, Stein Aerts · 2015 · PLoS Computational Biology
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
David Esopi, Mindy Kim Graham, Jacqueline A. Brosnan‐Cashman, Jennifer L. Meyers, Ajay M. Vaghasia, Anuj Kumar Gupta, Balasubramanian Kumar, Michael C. Haffner, Christopher M. Heaphy, Angelo Michael De Marzo et al. · 2020 · Cellular Oncology
Implications of telomerase reverse transcriptase in tumor metastasis
Yongkang Zou, Yu‐Sheng Cong, Junzhi Zhou · 2020 · BMB Reports
TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors
Božo Krušlin, Zoran Gatalica, Ondřej Hes, Faruk Skenderi, Markku Miettinen, Elma Contreras, Joanne Xiu, Michelle Ellis, Elena Florento, Semir Vranić et al. · 2021 · Clinical Genitourinary Cancer
Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review
Maria Sharmila Alina de Sousa, I Nunes, Yasmin Paz Christiano, Luiza Sisdelli, Janete Maria Cerutti · 2023 · Reviews in Endocrine and Metabolic Disorders
Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation
Marieke A. de Graaff, Jamie Yu, Hannah C. Beird, Davis R. Ingram, Theresa P. T. Nguyen, Jeffrey Juehui Liu, Svetlana V. Bolshakov, Károly Szuhai, Pierre Åman, Keila E. Torres et al. · 2016 · Laboratory Investigation
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer
Sebastian Thiem, Thomas Herold, Ulrich Krafft, Felix Bremmer, Yuri Tolkach, Attila Marcell Szász, Joerg Kriegsmann, Nadine Therese Gaisa, Christian Niedworok, Tibor Szarvas et al. · 2017 · Pathology International
Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
Soo Yeon Hahn, Tae Hyuk Kim, Chang‐Seok Ki, Sun Wook Kim, Soohyun Ahn, Jung Hee Shin, Jae Hoon Chung · 2017 · Oncotarget
Sc-ncDNAPred: A Sequence-Based Predictor for Identifying Non-coding DNA in Saccharomyces cerevisiae
Wenying He, Ying Ju, Xiangxiang Zeng, Xiangrong Liu, Quan Zou · 2018 · Frontiers in Microbiology
Detection of RET rearrangements in papillary thyroid carcinoma using RT-PCR and FISH techniques - A molecular and clinical analysis
Thomas Johannes Musholt, Julia I. Staubitz, Rafael J. A. Cámara, Petra B. Musholt, Diana Humberg, Erik Springer, Arno Schad · 2018 · European Journal of Surgical Oncology
Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma
Maria Teresa Samà, Enrico Grosso, Chiara Mele, Sara Laurora, Oriana Monzeglio, Paolo Marzullo, Renzo Luciano Boldorini, Paolo Aluffi Valletti, Gianluca Aimaretti, Maria Scatolini et al. · 2020 · Endocrine
Challenges in Cytology Specimens With Hürthle Cells
Eleni Thodou, Şule Canberk, Fernando Carlos Schmitt · 2021 · Frontiers in Endocrinology
G-Quadruplex Formed by the Promoter Region of the hTERT Gene: Structure-Driven Effects on DNA Mismatch Repair Functions
Anzhela V. Pavlova, Viktoriia Yu. Savitskaya, Nina G. Dolinnaya, Mayya V. Monakhova, Anastasia V. Litvinova, Elena Aleksandrovna Kubareva, Maria I. Zvereva · 2022 · Biomedicines
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation
Ming-Nan Chien, Po‐Sheng Yang, Yi‐Chiung Hsu, Tsang‐Pai Liu, Jie-Jen Lee, Shih‐Ping Cheng · 2018 · Head & Neck
Risk Factors for TERT Promoter Mutations with Papillary Thyroid Carcinoma Patients: A Meta-Analysis and Systematic Review
Jingxin Mao, Xingliang Huang, Mohammad K. Okla, Mostafa A. Abdel-Maksoud, Ayman Mubarak, Zahid Hameed, Razia Noreen, Aqsa Chaudhary, Shakira Ghazanfar, Yixuan Liao et al. · 2022 · Computational and Mathematical Methods in Medicine · Retracted
The telomere maintenance mechanism spectrum and its dynamics in gliomas
Sojin Kim, Tamrin Chowdhury, Hyeon Jong Yu, Jee Ye Kahng, Chae Eun Lee, Seung Ah Choi, Kyung‐Min Kim, Ho Jung Kang, Joo Ho Lee, Soon‐Tae Lee et al. · 2022 · Genome Medicine
GABP couples oncogene signaling to telomere regulation in TERT promoter mutant cancer
Andrew McKinney, Radhika Mathur, Nicholas O. Stevers, Annette M Molinaro, Susan Marina Chang, Joanna J. Phillips, J Costello · 2022 · Cell Reports
The prognostic power of gene mutations in thyroid cancer
Sara Ahmadi, Iñigo Landa · 2023 · Endocrine Connections
TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma
Xiaofeng Duan, Qiang Zhao · 2017 · Journal of Pediatric Hematology/Oncology
Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer
Carter J. Barger, Abigail Kora Suwala, Katarzyna M. Soczek, Albert Wang, Min Y. Kim, Chibo Hong, Jennifer A. Doudna, Susan Marina Chang, Joanna J. Phillips, David A. Solomon et al. · 2022 · Nature Communications
Genome-wide prediction of cancer driver genes based on SNP and cancer SNV data.
Quanze He, Quanyuan He, Xiaohui Liu, Youheng Wei, Suqin Shen, Xiaohui Hu, Qiao Li, Xiangwen Peng, Lin Wang, Long Yu · 2014 · Europe PMC (PubMed Central)
Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT
Martyn Bullock, Grace Lim, Cheng Li, In Ho Choi, Shivansh Kochhar, Chris Liddle, Lei Zhang, Roderick John Clifton-Bligh · 2016 · Oncotarget
Overlapping open reading frames strongly reduce human and yeast STN1 gene expression and affect telomere function
Victoria Torrance, David A. Lydall · 2018 · PLoS Genetics
TERT and BRAF in Thyroid Cancer: Teaming Up for Trouble
Joanne Yuen Yie Ngeow, Charis Eng · 2014 · Journal of Clinical Oncology
Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
Anna Schuh, Helene Marie-Pierre Dreau, Samantha J.L. Knight, Kate E. Ridout, Tuba Mizani, Dimitris V. Vavoulis, Richard T. Colling, Pavlos Antoniou, Erika M. Kvikstad, Melissa M. Pentony et al. · 2018 · Molecular Case Studies
Functional analysis of RPS27 mutations and expression in melanoma
Alfredo Floristán, Leah J. Morales, Douglas Hanniford, Carlos N. Martinez, Elena Castellano‐Sanz, Igor Dolgalev, Alejandro J. Ulloa-Morales, Eleazar Vega‐Saenz de Miera, Una Moran, Farbod Darvishian et al. · 2019 · Pigment Cell & Melanoma Research
The Strange Case of Jekyll and Hyde: Parallels Between Neural Stem Cells and Glioblastoma-Initiating Cells
David Bakhshinyan, Neil J. Savage, Sabra Khalid Salim, Chitra Venugopal, Sheila Kumari Singh · 2021 · Frontiers in Oncology
Iron-(Fe3+)-Dependent Reactivation of Telomerase Drives Colorectal Cancers
Raghuvaran Shanmugam, Prativa Majee, Wei Shi, Mert B. Ozturk, Thamil Selvan Vaiyapuri, Khaireen Idzham, Anandhkumar Raju, Seung Hee Shin, Kerem Fidan, Joo-Leng Low et al. · 2024 · Cancer Discovery
A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma
Tahereh Haghzad, Babak Khorsand, Seyedeh Adeleh Razavi, Mehdi Hedayati · 2024 · Endocrine
The search for cis-regulatory driver mutations in cancer genomes
Rebecca C. Poulos, Mathew A. Sloane, Luke B. Hesson, Jason W.H. Wong · 2015 · Oncotarget
hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer
Wojciech Barczak, Wiktoria Maria Suchorska, Agnieszka Sobecka, Karolina Anna Bednarowicz, Piotr Machczyński, Paweł Golusiński, Błażej Rubiś, Michał M. Masternak, Wojciech Golusiński · 2017 · Molecular Medicine Reports
Exploring hTERT promoter methylation in cutaneous T‐cell lymphomas
Alain Chebly, Joana Ropio, Jean‐Marie Péloponèse, Sandrine Poglio, Martina Prochazkova‐Carlotti, Floriane Cherrier, Jacky Ferrer, Yamina Idrissi, Evelyne Segal‐Bendirdjian, Éliane Chouery et al. · 2021 · Molecular Oncology
Targeting Protein Kinase C in Glioblastoma Treatment
Noelia Geribaldi‐Doldán, Irati Hervás-Corpión, Ricardo Gómez‐Oliva, Samuel Domínguez‐García, Félix A. Ruiz, Irene Iglesias Lozano, Livia Carrascal, Ricardo Pardillo-Díaz, José Luis Gil-Salú, Pedro Nunez‐Abades et al. · 2021 · Biomedicines
Clinical Application of TERT Promoter Mutations in Urothelial Carcinoma
Yujiro Hayashi, Kazutoshi Fujita, George Jabboure Netto, Norio Nonomura · 2021 · Frontiers in Oncology
Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors
James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken J. Kron, Rupert Hugh-White, Theodorus H. van der Kwast, Michael E. Fraser, Paul C. Boutros, Robert Glen Bristow et al. · 2021 · Cancer Research
Telomerase in hematologic malignancies
Claudia Bruedigam, Steven Lane · 2016 · Current Opinion in Hematology
Not the same thing: metastatic PTCs have a different background than ATCs
Dario de Biase, Federica Torricelli, Moira Ragazzi, Benedetta Donati, Elisabetta Kuhn, Michela Visani, Giorgia Acquaviva, Annalisa Pession, Giovanni Tallini, Simonetta Piana et al. · 2018 · Endocrine Connections
Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers
Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou · 2021 · npj Precision Oncology
Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma
Hee Young Na, Hyeong Won Yu, Woochul Kim, Jae Hoon Moon, Chang Ho Ahn, Sang Il Choi, Yeo Koon Kim, June Young Choi, So Yeon Park · 2022 · Clinical Endocrinology
Development of super-specific epigenome editing by targeted allele-specific DNA methylation
Nivethika Rajaram, Alexandra G. Kouroukli, Susanne Bens, Pavel Bashtrykov, Albert Jeltsch · 2023 · Epigenetics & Chromatin
Genomic and epigenomic integrative subtypes of renal cell carcinoma in a Japanese cohort
Akihiko Fukagawa, Natsuko Hama, Yasushi Totoki, Hiromi K. Nakamura, Yasuhito Arai, Mihoko Saito-Adachi, Akiko Miyagi Maeshima, Yoshiyuki Matsui, Shinichi Yachida, Tetsuo Ushiku et al. · 2023 · Nature Communications
Integrative analysis reveals clinical phenotypes and oncogenic potentials of long non-coding RNAs across 15 cancer types
Zelin Wang, Bin Li, Stephen Piccolo, Xiaoqin Zhang, Junhao Li, Hui Zhou, Jianhua Yang, Liang‐Hu Qu · 2016 · Oncotarget
TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes
João Vinagre, Joana Nabais, Jorge Pinheiro, Rui Batısta, Rui Caetano Oliveira, António Pedro Gonçalves, Ana Pestana, M. Reis, Bárbara Mesquita, Vasco Sá Pinto et al. · 2016 · Scientific Reports
Differential Allele-Specific Expression Uncovers Breast Cancer Genes Dysregulated by Cis Noncoding Mutations
Pawel F. Przytycki, Mona Singh · 2020 · Cell Systems
Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma
Soichiro Ako, Kazuhiro Nouso, Hideaki Kinugasa, Hiroshi Matsushita, Hiroyuki Terasawa, Takuya Adachi, Nozomu Wada, Yasuto Takeuchi, Mari Mandai, Hideki Onishi et al. · 2020 · Oncology
Elimination of MYCN-Amplified Neuroblastoma Cells by Telomerase-Targeted Oncolytic Virus via MYCN Suppression
Terutaka Tanimoto, Hiroshi Tazawa, Takeshi Ieda, Hiroshi Nouso, Morimichi Tani, Takanori Oyama, Yasuo Urata, Shunsuke Kagawa, Takuo Noda, Toshiyoshi Fujiwara · 2020 · Molecular Therapy — Oncolytics
TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder
Simone Bertz, Robert Stöhr, Nadine Therese Gaisa, Bernd Wullich, Arndt Hartmann, Abbas Agaimy · 2020 · Histopathology
Benign and Malignant Brenner Tumors Show an Absence of TERT Promoter Mutations That Are Commonly Present in Urothelial Carcinoma
Francesca Khani, Mairo L. Diolombi, Pallavi Khattar, Weihua Huang, John T. Fallon, Jonathan I. Epstein, Minghao Zhong · 2016 · The American Journal of Surgical Pathology
Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma
Shoko Kure, Ryuichi Wada, Zenya Naito · 2019 · Medical Molecular Morphology
Imaging biomarkers of TERT or GABPB1 silencing in TERT-positive glioblastoma
Noriaki Minami, Donghyun Hong, Nicholas O. Stevers, Carter J. Barger, Marina Radoul, Chibo Hong, Lee Chen, Yaewon Kim, Georgios Batsios, Anne Marie Gillespie et al. · 2022 · Neuro-Oncology
THOR is a targetable epigenetic biomarker with clinical implications in breast cancer
Joana Dias Apolónio, João S. Dias, Mónica Teotónio Fernandes, Martin Komosa, Tatiana Lipman, Cindy H. Zhang, Ricardo Romao Nazario Leao, Dong‐Hyun Lee, Nuno Miguel Nunes, Ana-Teresa Maia et al. · 2022 · Clinical Epigenetics
TERT promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancer
Shiyong Li, Junyu Xue, Ke Jiang, Yulu Chen, Lefan Zhu, Rengyun Liu · 2024 · Frontiers in Oncology
Genotyping of cutaneous melanoma.
Isabella C. Glitza, Michael A. Davies · 2014 · PubMed
Elevated TERT Expression in TERT-Wildtype Adult Diffuse Gliomas: Histological Evaluation with a Novel TERT-Specific Antibody
Kenta Masui, Takashi Komori, Yukinari Kato, Kenkichi Masutomi, Koichi Ichimura, Satoshi Ogasawara, Mika Kato Kaneko, Hiroharu Oki, Hiroyoshi Suzuki, Masayuki Nitta et al. · 2018 · BioMed Research International
Low Prevalence of TERT Promoter, BRAF and RAS Mutations in Papillary Thyroid Cancer in the Greek Population
Marilena Argyropoulou, Aristidis S. Veskoukis, Pagona-Maria Karanatsiou, Aikaterini Manolakelli, Ifigenia Kostoglou‐Athanassiou, George Vilaras, Andreas Karameris, Kalliopi N. Liadaki · 2018 · Pathology & Oncology Research
Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems
Yukihiko Sonoda · 2020 · International Journal of Clinical Oncology
Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)
Yang Liu, Na Li, Meng Wang, Zhang Yan-hua, Lu-Da Yan, Wen Zhou, Zhi-Qiong Yu, Xiaochun Peng, Jun Cai · 2021 · Oncology Reports
How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?
Jesmin Akter, Takehiko Kamijo · 2021 · Biomolecules
Genome-wide screens identify specific drivers of mutant hTERT promoters
Raghuvaran Shanmugam, Mert B. Ozturk, Joo-Leng Low, Semih Can Akıncılar, Joelle Y.H. Chua, Matan Thangavelu Thangavelu, Giridharan Periyasamy, Ramanuj DasGupta, Vinay Tergaonkar · 2022 · Proceedings of the National Academy of Sciences
Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas
Mónica S. Ventura Ferreira, Martina Margrit Crysandt, Till A. Braunschweig, Edgar Jost, Barbara Voss, Anne‐Sophie Bouillon, Ruth Knuechel, Tim H. Brümmendorf, Fabian Beier · 2018 · International Journal of Molecular Sciences
Presence and prevalence of UV related genetic mutations in uveal melanoma: similarities with cutaneous melanoma
Amanda Goh, Charmaine A. Ramlogan‐Steel, Kevin Sean Jenkins, Jason C. Steel, Christopher J. Layton · 2020 · Neoplasma
The Power of Fish Models to Elucidate Skin Cancer Pathogenesis and Impact the Discovery of New Therapeutic Opportunities
Sreeja Sarasamma, Yu‐Heng Lai, Sung‐Tzu Liang, Kechun Liu, Chung‐Der Hsiao · 2018 · International Journal of Molecular Sciences
Global multi-ancestry genome-wide analyses identify genes and biological pathways associated with thyroid cancer and benign thyroid diseases
Samantha White, Maizy S. Brasher, Jack W. Pattee, Wei Zhou, Sinéad Chapman, Yon Ho Jee, Caitlin Bell, Taylor L. Jamil, Martin Jose Barrio, Christopher H. Arehart et al. · 2026 · Nature Genetics
Role of a Promoter Mutation in TERT in Malignant Transformation of Pleomorphic Xanthoastrocytoma
Junji Hosono, Masayuki Nitta, Kenta Masui, Takashi Maruyama, Takashi Komori, Hideaki Yokoo, Taiichi Saito, Yoshihiro Muragaki, Takakazu Kawamata · 2018 · World Neurosurgery
Immune Checkpoint and Telomerase Crosstalk Is Mediated by miRNA-138 in Bladder Cancer
Hajar El Ahanidi, Meryem El Azzouzi, Chaimae Hafidi Alaoui, M. Tetou, Mounia Bensaid, Imane Chaoui, Laïla Benbacer, Ilias Hassan, Mohamed Oukabli, Katarzyna Michaud et al. · 2022 · Frontiers in Oncology
A clinical and molecular pathology prediction model for central lymph node metastasis in cN0 papillary thyroid microcarcinoma
Teng Ma, Lulu Wang, Wenxiao Song, Long Hao, Peng Shi, Mei Liang, Yafei Shi · 2023 · Frontiers in Endocrinology
Genetic regulation of TERT splicing affects cancer risk by altering cellular longevity and replicative potential
Oscar Flórez-Vargas, Michelle Ho, Maxwell H. Hogshead, Brenen W. Papenberg, Chia‐Han Lee, Kaitlin Forsythe, Kristine M. Jones, Wen Luo, Kedest Teshome, Cornelis Blauwendraat et al. · 2025 · Nature Communications
Urine TERT promoter mutations‑based tumor DNA detection in patients with bladder cancer: A pilot study
Mark Jain, David M. Kamalov, Alexander S. Tivtikyan, Alexander Balatsky, Larisa Mikhailovna Samokhodskaya, D A Okhobotov, Polina Kozlova, Eduard Pisarev, Maria I. Zvereva, Armais Albertovich Kamalov · 2021 · Molecular and Clinical Oncology
Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations
Sama Alohali, Alexandra E. Payne, Marc Philippe Pusztaszeri, Mohannad Rajab, Véronique‐Isabelle Forest, Michael P. Hier, Michael Tamilia, Richard J. Payne · 2023 · Cancers
BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
Ana Patricia Estrada-Florez, Mábel Bohórquez, Alejandro Vélez, Carlos S. Duque, Jorge Donado, Gilbert Mateus, César Panqueba, Guadalupe M. Polanco-Echeverry, Ruta Madhusudan Sahasrabudhe, Magdalena Echeverry et al. · 2019 · Endocrine Connections
Sex and smoking bias in the selection of somatic mutations in human bladder
Ferriol Calvet, Raquel Blanco Martínez-Illescas, Ferran Muiños, Maria Tretiakova, Elena S. Latorre-Esteves, Jeanne Fredrickson, Maria A. Andrianova, Stefano Pellegrini, Axel Rosendahl Huber, Joan E. Ramis-Zaldivar et al. · 2025 · Nature
Advances in Detecting Low Prevalence Somatic TERT Promoter Mutations in Papillary Thyroid Carcinoma
Vitor Rodrigues da Costa, Larissa Valdemarin Bim, Luiza Dornelles Penteado Pacheco e Silva, Gabriel Avelar Colozza‐Gama, André Uchimura Bastos, Rosana Delcelo, Gisele Oler, Janete Maria Cerutti · 2021 · Frontiers in Endocrinology
Urachal carcinoma: The journey so far and the road ahead
Rajesh Kumar, Seetha Harilal, Mohamed Abdelwahab Abdelgawad, Mohammed M. Ghoneim, Arun J. Kumar, Bijo Mathew · 2023 · Pathology - Research and Practice
TERT promoter mutations in gliomas: Molecular roles in tumorigenesis, metastasis, diagnosis, prognosis, therapeutic targeting, and drug resistance
Avaniyapuram Kannan Murugan, Siddarth Kannan, Ali Saeed Alzahrani · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma
Gary Lam, Rena R. Xian, Yingying Li, Kathleen H. Burns, KAREN L. BEEMON · 2016 · Genes
Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis
Seungjae Lee, Sumit Borah, Armita Bahrami · 2017 · Journal of Molecular Diagnostics
TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours—three examples from the clinical routine
Martin Harper Hysek, Johan O. Paulsson, Na Wang, Kenbugul Jatta, Claes Lindh, Nelson Fuentes-Martínez, Ivan Shabo, Jan Zedenius, C. Christofer Juhlin · 2018 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Concordance of somatic mutation profiles (BRAF, NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples
Shi Yang, Dominick A. Leone, Asok Biswas, April Deng, Drazen M. Jukic, Rajendra Pal Singh, Uma N. Sundram, Meera Mahalingam · 2018 · Human Pathology
Spindle cell liposarcoma with a TRIO-TERT fusion transcript
David Ilan Suster, Vikram Deshpande, Ivan A. Chebib, Martin S. Taylor, John Thomas Mullen, Miriam A. Bredella, G. Petur Nielsen · 2019 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin